Pancreatic Cancer Research

ResearcherHammersmith HospitalNo recent work listed

Leandro Castellano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3059-4829; OpenAlex author ID A5042431725. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 3 papers · 2014: 4 papers · 2015: 1 paper · 2016: none · 2017: none · 2018: 3 papers · 2019: 2 papers

Papers 16

  1. Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Last author DOI 10.1038/s41467-019-11752-2↗
  2. Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma? Co-author DOI 10.18632/oncotarget.26511↗
  3. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression. Last author DOI 10.1038/s41467-018-03962-x↗
  4. microRNAs: Novel regulators of the TGF-β pathway in pancreatic ductal adenocarcinoma. First author DOI 10.1080/23723556.2018.1499066↗
  5. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden. Co-author DOI 10.18632/oncotarget.24873↗
  6. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis. Co-author DOI 10.1016/j.ejca.2015.04.006↗
  7. Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. Co-author DOI 10.1001/jamasurg.2013.3643↗
  8. miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells. Co-author DOI 10.1080/15257770.2014.891741↗
  9. Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. Co-author DOI 10.1371/journal.pone.0090948↗
  10. A microRNA meta-signature for pancreatic ductal adenocarcinoma. Last author DOI 10.1586/14737159.2014.893192↗
  11. Towards a clinical use of miRNAs in pancreatic cancer biopsies. Co-author DOI 10.1586/erm.12.136↗
  12. Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer. Co-author DOI 10.1586/erm.13.31↗
  13. Circulating molecular markers in pancreatic cancer: ready for clinical use? Co-author DOI 10.2217/fon.12.187↗
  14. The role of miR-10b in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.surg.2012.03.021↗
  15. Loss of miR-126 is crucial to pancreatic cancer progression. Co-author DOI 10.1586/era.12.67↗
  16. microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma. Last author DOI 10.1586/era.11.184↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Adam Enver Frampton · 14 shared papers, 2011–2019 · strength 0.72
  2. Long R. Jiao · 12 shared papers, 2011–2019 · strength 0.64
  3. Jonathan Krell · 12 shared papers, 2011–2019 · strength 0.58
  4. Justin Stebbing · 12 shared papers, 2011–2019 · strength 0.57
  5. Tamara Gall · 7 shared papers, 2013–2019 · strength 0.36
  6. Elisa Giovannetti · 6 shared papers, 2014–2019 · strength 0.34
  7. Silvia Ottaviani · 3 shared papers, 2018–2019 · strength 0.31
  8. Niccola Funel · 4 shared papers, 2014–2019 · strength 0.23
  9. Nagy Adley Habib · 3 shared papers, 2015–2019 · strength 0.21
  10. Sladjana Zagorac · 2 shared papers, 2018–2019 · strength 0.14
  11. Sara Maria David Trabulo · 2 shared papers, 2018–2019 · strength 0.14
  12. Christopher Heeschen · 2 shared papers, 2018–2019 · strength 0.14
  13. Thomas Mathias Gress · 2 shared papers, 2018–2019 · strength 0.14
  14. Duncan R.C. Spalding · 1 shared paper, 2019 · strength 0.09
  15. Nigel Balfour Jamieson · 2 shared papers, 2014–2015 · strength 0.09
  16. Zaynab Jawad · 1 shared paper, 2018 · strength 0.07
  17. Mina Maftouh · 1 shared paper, 2014 · strength 0.04
  18. Amir Avan · 1 shared paper, 2014 · strength 0.04
  19. Godefridus J. Peters · 1 shared paper, 2014 · strength 0.04
  20. Yaojun Zhang · 1 shared paper, 2012 · strength 0.04
  21. D. Britton · 1 shared paper, 2014 · strength 0.03
  22. Ian Pike · 1 shared paper, 2014 · strength 0.03
  23. Debashis Sarker · 1 shared paper, 2014 · strength 0.03
  24. Yoh Zen · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.